Basic Study
Copyright ©The Author(s) 2022.
World J Stem Cells. Jul 26, 2022; 14(7): 539-555
Published online Jul 26, 2022. doi: 10.4252/wjsc.v14.i7.539
Table 1 Correlations between FOXO3 expression and the clinicopathological features of hepatocellular carcinoma patients, n (%)
Characteristics
n
FOXO3 expression
P value
Low
High
Age (yr)
> 505030 (60.00)20 (40.00)0.633
≤ 504022 (55.00)18 (45.00)
Gender
Male8046 (57.50)34 (42.50)1.000
Female106 (60.00)4 (40.00)
AJCC stage
I5225 (48.08)27 (51.92)0.029
II-III3827 (71.05)11 (28.95)
HBsAg
Negative198 (42.11)11 (57.89)0.119
Positive7144 (61.97)27 (38.03)
Recurrence
No4119 (46.34)22 (53.76)0.032
Yes4933 (67.35)16 (32.65)
AFP (μg/L)
> 4003319 (57.6)14 (42.4)0.976
≤ 4005733 (57.9)24 (42.1)
Total bilirubin (μmol/L)
>20155 (33.33)10 (66.67)0.036
≤ 207547 (62.67)28 (37.33)
ALT (U/L)
> 453120 (64.52)11 (35.48)0.348
≤ 455932 (54.24)27 (45.76)
GGT
> 405937 (62.7)22 (37.3)0.191
≤ 403115 (48.4)16 (51.6)
Edmondson-Steiner grade
I-II6128 (45.90)33 (54.10)0.001
III-IV2924 (82.76)5 (17.24)
Tumor number
Single7945 (56.97)34 (45.03)0.675
Multiple117 (63.64)4 (36.36)
Tumor size (cm)
> 52824 (85.71)4 (14.29)0.001
≤ 56228 (45.16)34 (54.84)
Table 2 Univariate and multivariate survival analysis of clinicpathological variables of hepatocellular carcinoma patients
Characteristics
Overall survival
Univariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
FOXO3 expression 0.311(0.134-0.721)0.0060.504(0.164-1.553)0.233
Low vs high
Age (yr)0.721(0.352-1.476)0.371
≤ 50 vs > 50
Gender0.520(0.124-2.176)0.371
Male vs female
AJCC stage 2.277(1.123-4.616)0.0221.203(0.555-2.604)0.640
I vs II-III
HBsAg 0.667(0.257-1.736)0.407
Negative vs positive
Recurrence87.223(4.860-1565.443)0.002
No vs yes
AFP (ng/mL) 0.888(0.434-1.818)0.746
≤ 400 vs > 400
Total bilirubin (μmol/L) 1.113(0.428-2.893)0.826
≤ 20 vs > 20
ALT (U/L) 1.046(0.504-2.171)0.903
≤ 45 vs > 45
GGT (U/L) 0.386(0.159-0.937)0.0350.594(0.233-1.516)0.276
≤ 40 vs > 40
Edmondson-Steiner grade3.664(1.791-7.497)< 0.0011.839(0.560-3.445)0.478
I-II vs III-IV
Tumor number 1.810(0.742-4.417)0.192
Singlevs vs multiple
Tumor size (cm) 0.504(0.250-1.018)0.056
≤ 5 vs > 5